Results 11 to 20 of about 17,628 (210)

Can primary optimal cytoreduction be predicted in advanced epithelial ovarian cancer preoperatively? [PDF]

open access: yesWorld Journal of Surgical Oncology, 2010
Introduction Prediction of optimal cytoreduction in patients with advanced epithelial ovarian caner preoperatively. Methods Patients with advanced epithelial ovarian cancer who underwent surgery for the first time from Jan.
Behtash Nadereh   +5 more
doaj   +2 more sources

Safety and Efficacy of Pre-Cytoreduction Prior to Definitive Multi-Agent Chemotherapy in Aggressive Lymphoma

open access: yesPakistan Journal of Medicine and Dentistry
Background: Pre-cytoreduction refers to the administration of initial chemotherapy to reduce tumor burden prior to initiating definitive multi-agent chemotherapy.
Reena Kumari Sunil   +3 more
doaj   +2 more sources

Impact of tumor cytoreduction in metastatic prostate cancer

open access: yesResearch and Reports in Urology, 2019
Yaya Sow, Ousmane Sow, Boubacar Fall, Babacar Sine, Alioune Sarr, Cyrille Zé Ondo, Babacar Diao, Alain Khassim Ndoye, Mamadou BaUrology and Andrology Department at Aristide Le Dantec Hospital, Cheikh Anta Diop University, Dakar, SenegalObjective ...
Sow Y   +8 more
doaj   +1 more source

Cytoreduction can reduce the recurrence rate of patients with occult uterine sarcoma undergoing morcellation: a retrospective study

open access: yesClinical and Experimental Obstetrics & Gynecology, 2022
Background: Tumor morcellation happened to facilitate iatrogenic metastasis for patients with occult uterine sarcoma. The optimal completion surgery for these patients needed to be established.
Chao Ding, Jianqing Zhu
doaj   +2 more sources

Feasibility and Safety of Venetoclax for Cytoreduction During Induction Therapy in Newly Diagnosed Acute Promyelocytic Leukemia. [PDF]

open access: yesEur J Haematol
ABSTRACT Objective This study aimed to evaluate the feasibility and safety of venetoclax as a cytoreductive strategy during induction therapy in newly diagnosed acute promyelocytic leukemia (APL), and to provide an exploratory description of its early efficacy.
Wang Y, Xiao R, Huang X, Xiao Y.
europepmc   +2 more sources

Upper-Abdominal Cytoreduction for Advanced Ovarian Cancer—Therapeutic Rationale, Surgical Anatomy and Techniques of Cytoreduction

open access: yes, 2022
Cytoreductive surgery (CRS) is the cornerstone of treating advanced ovarian cancer. Approximately 60–70% of patients with advanced ovarian cancer will have involvement in the upper abdomen or the supracolic compartment of the abdominal cavity ...
Olivier Glehen   +3 more
core   +1 more source

Pre‐transplantation cytoreduction does not benefit advanced myelodysplastic syndrome patients after myeloablative transplantation with grafts from family donors

open access: yesCancer Communications, 2021
Background The role of pre‐hematopoietic stem cell transplantation (HSCT) cytoreduction with either induction chemotherapy (IC) or hypomethylating agents (HMAs) in treating advanced myelodysplastic syndrome (MDS) remains debatable.
Yu‐Qian Sun   +7 more
doaj   +1 more source

A Cohort Study to Decode the Application of Peritoneal Carcinomatosis Index in Predicting the Prognosis of Advanced Ovarian Malignancies [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2022
Introduction: Peritoneal Carcinomatosis Index (PCI) is used to assess the extent of peritoneal cancer by dividing the peritoneal cavity into 13 well-defined regions and assessing the size of the largest tumour nodule in each region. Aim: To evaluate the
Athul Damodaran   +2 more
doaj   +1 more source

The application of pringle manoeuvre, type three liver mobilisation, full thickness diaphragmatic resection with primary closure technique and peritonectomy in the management of advanced ovarian malignancy [PDF]

open access: yesObstetrics & Gynecology Science, 2023
Objective We present an educational technique for the safe completion of complete cytoreduction of diaphragmatic disease for the management of advanced ovarian malignancy.
Sarah Louise Smyth   +1 more
doaj   +1 more source

The impact of time and team on primary cytoreduction outcomes [PDF]

open access: yes, 2016
The degree of cytoreduction at time of initial surgery for epithelial ovarian cancers is correlated with overall survival. Given that surgery can be physically and mentally taxing on the surgeon, we sought to examine if there were temporal and/or team ...
Heather Williams   +15 more
core   +1 more source

Home - About - Disclaimer - Privacy